Overview

NSAIDs Stent Study

Status:
Recruiting
Trial end date:
2023-04-01
Target enrollment:
Participant gender:
Summary
This is a pilot study to (1) evaluate the effect of Ketorolac on inflammatory response and its impact on stent related symptoms in patients undergoing stent placement procedure and (2) assess feasibility of recruitment, randomization, assessment procedures and implementation of the study intervention.
Phase:
Early Phase 1
Details
Lead Sponsor:
Washington University School of Medicine
Treatments:
Ketorolac
Ketorolac Tromethamine